MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+41.71%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$376M
AUM Growth
+$376M
(+130%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
31.63%
Top 10 Holdings %
Top 10 Hldgs %
99.83%
Holding
13
New
3
Increased
1
Reduced
–
Closed
2
Top Buys
| 1 |
Repare Therapeutics
RPTX
|
$74.1M |
| 2 |
ADC Therapeutics
ADCT
|
$25.3M |
| 3 |
Merus
MRUS
|
$11.3M |
Top Sells
| 1 |
CytomX Therapeutics
CTMX
|
$6.56M |
| 2 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$1.17M |
Sector Composition
| 1 | Healthcare | 88.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Repare Therapeutics
RPTX
$71.7M
| $74.1M | 19.7% | +2,388,337 | New | +$74.1M |
|
|
HARP
2
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $64.7M | 17.21% | 3,898,422 | – | – |
|
|
TCRR
3
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $51.8M | 13.77% | 3,370,982 | – | – |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $37.4M | 9.96% | 2,331,534 | – | – |
|
|
GTHX
5
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $34.5M | 9.18% | 1,423,794 | – | – |
|
|
6
ADC Therapeutics
ADCT
$345M
| $25.3M | 6.72% | +539,648 | New | +$25.3M |
|
|
TPTX
7
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $19.9M | 5.3% | 308,686 | – | – |
|
8
Y-mAbs Therapeutics
YMAB
$388M
| $14.6M | 3.87% | 337,291 | – | – |
|
|
9
Merus
MRUS
$4.98B
| $11.3M | 3% | +700,879 | New | +$11.3M |
|
|
AUTL
10
Autolus Therapeutics
AUTL
$399M
| $637K | 0.17% | 39,740 | – | – |
|
|
11
CytomX Therapeutics
CTMX
$336M
| – | – | -855,437 | Closed | -$6.56M |
|
|
VIRX
12
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – | -2,809,912 | Closed | -$1.17M |
|